This webinar will provide the background on cost-effectiveness analyses (CEAs), CEAs evaluating pharmacogenomic testing implementation using real-world data, background on models used in CEAs, and CEA studies using modeling or simulations evaluating pharmacogenomic testing in psychiatry, oncology, cardiology, and other therapeutic areas.
About the speaker
Ryan Gregg, PhD is the Medical Science Liaison for the northeast and southeast at OneOme. He obtained a B.S. with honors in forensic chemistry from the University of Mississippi, and a Ph.D. in pharmacology from the center for substance abuse and research at Temple University School of Medicine. Ryan has a diverse background of experience in pre-clinical and clinical research in psychiatry, hematology, and oncology that has helped him gain an appreciation for the financial challenges facing healthcare, and the importance of implementing cost-effective practices.